tiprankstipranks
Trending News
More News >
Moderna (MRNA)
NASDAQ:MRNA
US Market

Moderna (MRNA) Technical Analysis

Compare
17,051 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is -1.34, suggesting Moderna is a Sell.
Moderna’s (MRNA) 20-Day exponential moving average is 27.21, while Moderna’s (MRNA) share price is $27.22, making it a Buy.
Moderna’s (MRNA) 50-Day exponential moving average is 30.44, while Moderna’s (MRNA) share price is $27.22, making it a Sell.

Moderna (MRNA) Pivot Points

Apr 26, 2025, 10:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
25.60
25.96
26.68
27.04
27.76
28.12
28.84
Fibonacci
25.96
26.38
26.63
27.04
27.46
27.71
28.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Apr 26, 2025, 10:43 AM
Period
Simple
Exponential
MA5
26.40Buy
26.64Buy
MA10
26.12Buy
26.43Buy
MA20
26.39Buy
27.21Buy
MA50
30.69Sell
30.44Sell
MA100
35.12Sell
37.86Sell
MA200
54.16Sell
60.41Sell
Moderna’s (MRNA) 10-Day exponential moving average is 26.43, while Moderna’s (MRNA) share price is $27.22, making it a Buy.
Moderna’s (MRNA) 100-Day exponential moving average is 37.86, while Moderna’s (MRNA) share price is $27.22, making it a Sell.
Moderna’s (MRNA) stock price is $27.22 and Moderna’s (MRNA) 50-day simple moving average is 30.69, creating a Sell signal.
Moderna’s (MRNA) stock price is $27.22 and Moderna’s (MRNA) 100-day simple moving average is 35.12, creating a Sell signal.
Moderna’s (MRNA) stock price is $27.22 and Moderna’s (MRNA) 200-day simple moving average is 54.16, creating a Sell signal.

Moderna (MRNA) Technical Indicators

Apr 26, 2025, 10:43 AM
Name
Value
Implied Action
RSI (14)
47.00
Neutral
STOCH (9,6)
81.88
Sell
STOCHRSI (14)
82.45
Sell
MACD (12,26)
-1.34
Sell
ADX (14)
18.69
Buy
Williams %R
-13.95
Sell
CCI (14)
49.15
Neutral
ATR (14)
1.93
-
Ultimate Oscillator
57.25
Neutral
ROC
8.40
Buy
Moderna’s (MRNA) Relative Strength Index (RSI) is 47.00, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 18.69, creating a Buy signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is 49.15, creating a Neutral signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is 8.40, creating a Buy signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Hold.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 47.00, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is -1.34, which suggests MRNA is a Sell.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 26.40, which suggests MRNA is a Buy.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 26.39, which suggests MRNA is a Buy.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 30.69, which suggests MRNA is a Sell.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 54.16, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -13.95, which suggests MRNA is a Sell.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is 49.15, which suggests MRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis